Tin tức & Cập nhật

New drug applications approved by US FDA as of 01-15 November  2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Among patients with recurrent gastrointestinal (GI) bleeding due to small-intestinal angiodysplasia (SIA), treatment with thalidomide resulted in fewer bleeding episodes compared with placebo, according to a recent study.

Frequently adding salt to foods increases not only the risk of hypertension but the risk of type 2 diabetes (T2D) as well, as reported in a large study.

Patients with axial spondyloarthritis (axSpA) who are in a low disease activity (LDA) state or in remission tend to experience residual disease, which occurs more frequently among female patients, reveals a recent study.

An updated patient-level meta-analysis refutes claims that paclitaxel-coated devices for femoropopliteal interventional procedures heighten the risk of death. The recent study presented at TCT 2023 has found no association between exposure to paclitaxel and mortality.

In children with treatment-resistant dysfunctional voiding, the use of botulinum toxin-A (BTX-A) helps with postvoid residuals (PVR), urinary tract infections (UTIs), and incontinence, according to a study.

Women undergoing high-risk percutaneous coronary intervention (HR PCI) appear to have better survival outcomes following hospital discharge compared with men, despite being older and having a more complex coronary artery disease, according to data from the IMPELLA-PL registry.